NORDITROPIN

This brand name is authorized in United States. It is also authorized in Albania, Australia, Austria, Brazil, Canada, Finland, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug NORDITROPIN contains one active pharmaceutical ingredient (API):

1	Somatropin UNII NQX9KB6PCL - SOMATROPIN
	Somatropin is a potent metabolic hormone of importance for the metabolism of lipids, carbohydrates and proteins. In children with inadequate endogenous growth hormone, somatropin stimulates linear growth and increases growth rate. In adults, as well as in children, somatropin maintains a normal body composition by increasing nitrogen retention and stimulation of skeletal muscle growth, and by mobilization of body fat.
	Read more about Somatropin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01AC01	Somatropin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AC Somatropin and somatropin agonists
Discover more medicines within H01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	123/93
AU	Pharmaceutical Benefits Scheme	10432C, 10449Y, 10451C, 10467X, 10489C, 10496K, 11895C, 5818F, 5819G, 5820H
BR	Câmara de Regulação do Mercado de Medicamentos	526600911158411, 526602201158412, 526602202154410, 526602203150419, 526617020008203, 526617020008303, 526620080008007, 526620080008107, 526620080008207
CA	Health Products and Food Branch	02334852, 02334860, 02334879
ES	Centro de información online de medicamentos de la AEMPS	62977, 62978, 62979, 85644, 85645, 85646
FI	Lääkealan turvallisuus- ja kehittämiskeskus	017019, 017070, 025480
GB	Medicines & Healthcare Products Regulatory Agency	186369, 309380, 309383, 386089, 386093, 386095, 394083, 394086, 41042, 41052, 41993
IE	Health Products Regulatory Authority	88114, 88115, 88830, 88831, 88832
IL	מִשְׂרַד הַבְּרִיאוּת	8086, 8087
JP	医薬品医療機器総合機構	2412402P6027, 2412402P7023, 2412402P8020
LT	Valstybinė vaistų kontrolės tarnyba	1004103, 1018082, 1018083, 1019767, 1019768, 1019769, 1037188, 1037189, 1057733, 1057734, 1091619, 1091620, 1091621, 1091622, 1091623, 1091624
MT	Medicines Authority	MA104/00103, MA104/00104, MA104/00105, MA104/00106
NL	Z-Index G-Standaard	14286998, 14287005, 14287013
NL	Z-Index G-Standaard, PRK	53082, 53090, 53104, 72729, 72745
NZ	Medicines and Medical Devices Safety Authority	11501, 11502, 11503
PL	Rejestru Produktów Leczniczych	100157810, 100412811, 100436869
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W54046001, W54046002, W54046003, W66430001, W66430002, W66430003
SG	Health Sciences Authority	12215P, 12219P
TN	Direction de la Pharmacie et du Médicament	5993091H, 5993092H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699676950225, 8699676950232, 8699676950249
US	FDA, National Drug Code	0169-7703, 0169-7704, 0169-7705, 0169-7708
ZA	Health Products Regulatory Authority	33/21.10/0420, 33/21.10/0421, 33/21.10/0422